Assignee
XRAD THERAPEUTICS INC
US·1 granted patent·2 pending applications·1 citations·filing 2020–2022
Top patents by PatentIndex Score
3 records- 0175US12187742B2Dual ATM and DNA-PK inhibitors for use in anti-tumor therapyXRAD THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·1 cites·25 claims
- 0251US2025268873A1Combination of dual atm and dna-pk inhibitors and immunotherapeutic agents for use in cancer therapyXRAD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0349US2022142995A1Dual atm and dna-pk inhibitors for use in anti-tumor therapyXRAD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →